Earth Life Sciences Inc.

Earth Life Sciences Inc.

OOTC:CLTS
0.00
USD
0.00
(0.00%)
0.00EPS
6.50MMarket Cap
2009 Y
2010 Y
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
TTM
Revenue per Share
- -
0.02
0.02
0.08
0.12
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
-11.51
-0.09
-0.33
-0.26
-0.11
-0.05
-0.01
- -
-0.03
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
0.55
- -
0.01
-0.01
- -
-0.06
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-43.6
-0.48
-0.81
-1.08
-1.12
-0.78
0.02
0.02
- -
- -
- -
- -
- -
- -
Tangible Book Value per Share
-43.6
-0.48
-0.81
-1.08
-1.12
-0.78
0.02
0.02
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
1
1
1
1
1
145
271
271
333
333
438
495
851
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
-662.72
-1,323.09
-332.82
-93.58
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
-1
- -
-7
- -
- -
-2
-2
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
-553.6
-1,334.91
-330.22
-90.87
- -
- -
- -
- -
- -
- -
- -
- -
- -
Working Capital
- -
- -
-1
-1
-1
-1
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
-1
-1
-1
-1
7
6
- -
- -
- -
- -
4
4
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
-1.86
- -
- -
- -
- -
- -
- -

Capital Structure

USD

•

in mil. unless spec.
Dec'21
Jun'22
Sep'22
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
961
1,000
1,000
Market Capitalization
6
10
6

Working Capital

USD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-334.96%
-448.31%
-2,107.74%
Free Cash Flow
- -
- -
-65.04%
Net Income, GAAP
1,076.7%
1,717.09%
-13.3%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -

Company Description

CEO
Angelo M. Marino
Full Time Employees
74
Sector
Non-energy minerals
Industry
Other metals/Minerals
Address
50 West Liberty Street Reno NV United States 89501
IPO Date
Dec 10, 2003
Business
Earth Life Sciences Inc. (CLTS) is a development-stage company focused on acquiring and developing software technologies for the transportation and digital healthcare sectors; it provides an AI-driven mileage-based loyalty system for public transportation and operates the VivaHealth platform, a one-stop smart life service trading platform offering online ordering and offline matching services such as physiotherapy, foot bathing, skincare, beauty and makeup, manicure, haircuts, traditional Chinese massage, and medical professional services targeted at Asian elderly communities, primarily Chinese and other Asian populations, in North America. Founded in 2001 and headquartered in Reno, Nevada, the company, led by CEO Angelo M. Marino, operates primarily in the United States with plans for nationwide expansion covering hundreds of cities and millions of users; it leverages artificial intelligence, big data, and O2O (online-to-offline) models to integrate service resources and enhance efficiency in personal care and healthcare delivery. In recent developments, Earth Life Sciences acquired the VIVA Health HK Limited platform in 2021 to enter the U.S. healthcare market, announced revenue targets in 2022 projecting up to $17.9 million initially from VivaHealth targeting the growing Asian elderly demographic with substantial spending power, and continues to position Viva USA for EBITDA profitability by 2024 through platform customization and broad rollout amid the multi-trillion-dollar personal care segment of the healthcare industry.